Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin ± all-trans retinoic acid ± granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Elihu H. Estey, Peter F. Thall, Sherry Pierce, Jorge Cortes, Miloslav Beran, Hagop Kantarjian, Michael J. Keating, Michael Andreeff, Emil Freireich

Research output: Contribution to journalArticle

179 Scopus citations

Fingerprint Dive into the research topics of 'Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin ± all-trans retinoic acid ± granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds